![John Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Doyle
Director of Finance/CFO at
COGNITION THERAPEUTICS, INC.
Net worth: 730 352 $ as of 2026-05-30
Profile
John Doyle is Chief Financial & Accounting Officer at Cognition Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at 4D Pharma Plc from 2022 to 2023, Chief Financial Officer, Treasurer & Senior VP at Chiasma, Inc. in 2021, Vice President-Finance & Investor Relations at Verastem, Inc. from 2019 to 2020, Head-Financial Planning & Analysis at SimpliVity Corp.
from 2016 to 2018, Director-Business Unit Financial Planning at PAREXEL International Corp.
from 2015 to 2016.
Education includes undergraduate studies at the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-30 | 618,942 ( 0.69% ) | 730 352 $ | 2026-05-30 |
John Doyle active positions
| Companies | Position | Start |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Director of Finance/CFO | 2023-04-30 |
Former positions of John Doyle
| Companies | Position | End |
|---|---|---|
| 4D PHARMA PLC | Director of Finance/CFO | 2023-03-29 |
| CHIASMA, INC. | Director of Finance/CFO | 2021-08-04 |
| VERASTEM, INC. | Investor Relations Contact | 2020-11-30 |
SimpliVity Corp.
 SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Corporate Officer/Principal | 2018-01-31 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 2016-03-31 |
Training of John Doyle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Technology Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
- Stock Market
- Insiders
- John Doyle
